Management of complicated multirecurrent pterygia using multimicroporous expanded polytetrafluoroethylene
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Kyoung Woo | - |
dc.contributor.author | Kim, Jae Chan | - |
dc.contributor.author | Moon, Jun Hyung | - |
dc.contributor.author | Koo, Hyun | - |
dc.contributor.author | Kim, Tae Hyung | - |
dc.contributor.author | Moon, Nam Ju | - |
dc.date.available | 2019-03-09T01:43:42Z | - |
dc.date.issued | 2013-06 | - |
dc.identifier.issn | 0007-1161 | - |
dc.identifier.issn | 1468-2079 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14580 | - |
dc.description.abstract | Aims To evaluate the efficiency of multimicroporous expanded polytetrafluoroethylene (e-PTFE) insertion in complicated multirecurrent pterygia. Methods A total of 62 eyes from 62 patients with a multirecurrent pterygium associated with symblepharon or motility restriction-related binocular diplopia were recruited. All eyes underwent pterygia excision followed by application of 0.033% mitomycin C, amniotic membrane transplantation and conjunctival limbal autograft. Multimicroporous e-PTFE was then inserted intraoperatively in 30 eyes between the transplanted amniotic membrane and the conjunctiva (group A), but not inserted in the other 32 eyes (group B). The main outcome measures were symblepharon formation, motility restriction, binocular diplopia, subjective score of conjunctival hyperaemia and postoperative pterygium recurrence. Results In the mean follow-up period of 17.2 +/- 2.3 months, symblepharon formation, motility restriction, diplopia and conjunctival hyperaemia were significantly improved after surgery in group A patients (p=0.000, 0.000, 0.008 and 0.000, respectively). Postoperative symblepharon formation, motility restriction and conjunctival hyperaemia were significantly less in group A compared to group B (p=0.024, 0.027 and 0.000, respectively). After surgery, corneal recurrence developed in one eye (3.3%) from group A, which was significantly lower than the eight eyes (25%) from group B (p=0.027). Conclusions Multimicroporous e-PTFE insertion may provide a novel approach for treating intractable complicated multirecurrent pterygia. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | BMJ PUBLISHING GROUP | - |
dc.title | Management of complicated multirecurrent pterygia using multimicroporous expanded polytetrafluoroethylene | - |
dc.type | Article | - |
dc.identifier.doi | 10.1136/bjophthalmol-2012-302784 | - |
dc.identifier.bibliographicCitation | BRITISH JOURNAL OF OPHTHALMOLOGY, v.97, no.6, pp 694 - 700 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000319271300006 | - |
dc.identifier.scopusid | 2-s2.0-84878013828 | - |
dc.citation.endPage | 700 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 694 | - |
dc.citation.title | BRITISH JOURNAL OF OPHTHALMOLOGY | - |
dc.citation.volume | 97 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordPlus | AMNIOTIC MEMBRANE TRANSPLANTATION | - |
dc.subject.keywordPlus | LIMBAL CONJUNCTIVAL AUTOGRAFT | - |
dc.subject.keywordPlus | RECURRENT PTERYGIUM | - |
dc.subject.keywordPlus | MITOMYCIN-C | - |
dc.subject.keywordPlus | FIBROBLASTS | - |
dc.subject.keywordPlus | EXCISION | - |
dc.subject.keywordPlus | MOTILITY | - |
dc.subject.keywordPlus | REMOVAL | - |
dc.subject.keywordPlus | GRAFTS | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.